Samsara BioCapital »

Onkure Therapeutics Inc-a shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2025-03-31 $3.5M 824k 4.30
2024-12-31 $7.1M 824k 8.60

More positions owned by Samsara BioCapital

Mineralys Therapeutics (MLYS)
Scholar Rock Hldg Corp (SRRK)
Kalaris Therapeutics (KLRS)
Septerna (SEPN)
Neurogene (NGNE)
Alumis (ALMS)
Upstream Bio (UPB)
Gossamer Bio (GOSS)
Lenz Therapeutics (LENZ)
Aquestive Therapeutics (AQST)
Palvella Therapeutics Inc Ne (PVLA)
Avadel Pharmaceuticals Com Shs (AVDL)
Vtv Therapeutics Cl A New (VTVT)
Nkarta (NKTX)
Contineum Therapeutics Cl A (CTNM)

View all positions for Samsara BioCapital

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a